EzDx — Making Precision Diagnostics Accessible to Everyone
Accurate. Accessible. Affordable.
EzDx (Hangzhou EzDx Technology Co., Ltd.) is an innovative biotechnology company dedicated to making precision diagnostics more accessible, convenient, and affordable for everyone. Guided by our "3A Diagnostics" philosophy—Accurate, Accessible, and Affordable—we strive to transform conventional laboratory-based testing into intelligent, user-friendly diagnostic solutions that bring reliable results directly to the point of need.
As a pioneer in AI- and Internet of Things (AIoT)-enabled molecular diagnostics, EzDx develops innovative technologies that integrate portable nucleic acid testing instruments, smartphone connectivity, intelligent data analysis, and cloud-based management. Our solutions empower individuals, healthcare professionals, and field operators to perform molecular testing at home or on-site, reducing dependence on centralized laboratories and enabling faster, more informed decision-making.
EzDx offers a comprehensive portfolio of compact, portable, and cost-effective molecular diagnostic platforms, including the WeD series, designed to support rapid and reliable point-of-care testing (POCT). With selected assays delivering results in as little as 20 minutes, our technologies support a wide range of applications, including:
- Human Health: Molecular detection of pathogens associated with respiratory, gastrointestinal, and sexually transmitted infections.
- Veterinary and Animal Health: Rapid on-site detection of infectious diseases affecting livestock, poultry, aquaculture species, and companion animals.
- Consumer Genetics: Accessible genetic testing for ancestry, inherited traits, and personal wellness.
- Precision Oncology: Development of innovative liquid biopsy technologies for cancer detection, molecular profiling, and minimal residual disease (MRD) monitoring.
Beyond diagnostic instruments, EzDx is building an intelligent, connected diagnostic ecosystem that integrates molecular testing, automated data interpretation, digital reporting, and cloud-based disease surveillance. By combining advanced molecular technologies with AI-driven analytics and connected devices, we aim to make high-quality diagnostics available beyond traditional laboratory settings.
Building on our expertise in portable molecular diagnostics, programmable enzyme technologies, and intelligent biosensing, EzDx is also advancing next-generation liquid biopsy solutions for ultrasensitive detection of cancer-associated biomarkers and MRD, with the goal of supporting earlier intervention and more personalized disease management.
At EzDx, we believe precision diagnostics should not be limited by location, infrastructure, or cost. Our mission is to bring laboratory-quality molecular testing closer to everyone—anytime, anywhere.
